July/August 2026
July/August 2026 | Features
Therapies for IRDs: Moving Beyond Single-Gene Solutions
Emerging gene-agnostic strategies target shared pathways and offer options for IRD patients without mutation-specific therapies.
Aykut Demirkol, MD; Rajvir Solanky; Jayvin Hernandez-Reyes; Ilay Demirkol; and Kuzey Soydas
July/August 2026 | Features
IRD Clinical Trial Endpoints: Lessons Learned
Choosing the right outcome measures for inherited retinal disease trials requires matching endpoints to disease biology, therapeutic mechanism, and patient experience.
Melissa Yuan, MD, and Ahmad Al Moujahed, MD, PhD
Popular Articles
May/June 2026 Supplement | Editorial
The Economics Of Care
Alan Ruby, MD
March 2026 | Meeting Minutes
ACRC and Macula 2026: A Summary
The annual meeting boasted top-notch clinical and surgical education, honored guests, and comradery.
Justin C. Muste, MD; Collin Richards, MD; Timothy Xu, MD; and Erik Massenzio, MD
July/August 2026 | Visually Speaking
FA Imaging in Behçet Disease
Imaging is essential for diagnosis, disease staging, and prognostication.
Kanwaljeet Harjot Madan, MS(Ophth), FAICO